Ardent Health (ARDT) Expected to Announce Quarterly Earnings on Wednesday

Ardent Health (NYSE:ARDT) will likely be announcing its Q3 2025 results after the market closes on Wednesday, November 12th. Analysts expect the company to announce earnings of $0.42 per share and revenue of $1.5460 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Thursday, November 13, 2025 at 9:00 AM ET.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.30 by $0.22. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.54 billion. On average, analysts expect Ardent Health to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ardent Health Stock Down 0.6%

ARDT opened at $14.59 on Wednesday. The firm has a 50-day simple moving average of $13.77 and a two-hundred day simple moving average of $13.31. Ardent Health has a 52 week low of $10.10 and a 52 week high of $18.19. The company has a market capitalization of $2.09 billion, a PE ratio of 8.06, a price-to-earnings-growth ratio of 6.49 and a beta of 0.44. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66.

Institutional Investors Weigh In On Ardent Health

A number of institutional investors and hedge funds have recently modified their holdings of ARDT. New York State Common Retirement Fund increased its stake in Ardent Health by 121.4% in the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after purchasing an additional 3,400 shares during the period. Marshall Wace LLP purchased a new position in Ardent Health during the 2nd quarter worth $147,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Ardent Health by 103.8% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 14,104 shares of the company’s stock worth $194,000 after purchasing an additional 7,182 shares during the period. Creative Planning bought a new position in shares of Ardent Health during the 2nd quarter worth $216,000. Finally, WINTON GROUP Ltd bought a new position in shares of Ardent Health during the 2nd quarter worth $228,000.

Analyst Ratings Changes

A number of equities research analysts recently commented on ARDT shares. KeyCorp decreased their target price on Ardent Health from $24.00 to $20.00 and set an “overweight” rating on the stock in a research report on Thursday, August 7th. UBS Group started coverage on Ardent Health in a research note on Wednesday, September 10th. They issued a “buy” rating and a $17.00 price objective on the stock. JPMorgan Chase & Co. cut their target price on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating for the company in a report on Monday, August 11th. Wall Street Zen raised shares of Ardent Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 9th. Finally, Weiss Ratings upgraded shares of Ardent Health from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, October 24th. Nine investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $19.30.

Ardent Health Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.